The World Health Organization (WHO) has published its latest Global Antimicrobial Resistance and Use Surveillance (GLASS) Report, drawing on data from 104 countries. The 2025 edition reveals increasing resistance among common pathogens, especially in regions with limited diagnostic capacity, and highlights the need for safer antibiotic use and improved global surveillance.
A major contribution to the report came from OUCRU Indonesia. Professor Raph Hamers and Dr Gilbert Lazarus led systematic reviews comparing global antibiotic resistance data reported in peer-reviewed literature (2018–2023) with WHO’s GLASS surveillance findings. Their work, featured in Chapter 4, found that resistance levels in published studies—often from large hospitals—were sometimes higher than those captured in national surveillance systems. Nevertheless, both sources confirmed widespread and rising resistance in key bacteria like Acinetobacter spp., Staphylococcus aureus, and Salmonella spp.
“Contributing to this important WHO report is part of OUCRU’s commitment to advancing evidence-based research on antimicrobial resistance,” said Raph, Head of the Clinical Infectious Diseases Research Programme at OUCRU Indonesia. “We are proud to work alongside WHO and partners to help strengthen the global evidence base needed for better policy and action.”
OUCRU’s contributions reflect its strong commitment to evidence-based research on AMR. Ongoing projects such as ACORN, NASPA, and the PRYSMA trial continue to support regional and global action to combat AMR.
Visit the Global antibiotic resistance surveillance report 2025 on the WHO website